Abstract
ICRF-187 was tested for cardioprotective activity in doxorubicin-treated mice and guinea pigs. Pretreatment with i.p. ICRF-187 caused a significant decrease in the indicence of i.v. doxorubicin-induced myocardial histological damage in the mouse. I.p. ICRF-187 did not, however, reduce the effect of i.p. doxorubicin on a functional myocardial effect of this antitumour drug, a reduced histamine responsiveness of right atria in vitro. These data suggest that ICRF-187 may not be specific for all the cardiac effects of doxorubicin.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertazzoli C., Bellini O., Magrini U., Tosana M. G. Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1877–1883. [PubMed] [Google Scholar]
- Breed J. G., Zimmerman A. N., Meyler F. L., Pinedo H. M. The interval-force relationship: a technique for evaluating the cardiac toxicity of anthracycline analogs. Cancer Treat Rep. 1979 May;63(5):869–873. [PubMed] [Google Scholar]
- Herman E. H., Ferrans V. J., Jordan W., Ardalan B. Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits. Res Commun Chem Pathol Pharmacol. 1981 Jan;31(1):85–97. [PubMed] [Google Scholar]
- Herman E. H., Ferrans V. J. Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187). Cancer Res. 1981 Sep;41(9 Pt 1):3436–3440. [PubMed] [Google Scholar]
- Lampidis T. J., Moreno G., Salet C., Vinzens F. Nuclear and mitochondrial effects of adriamycin in singly isolated pulsating myocardial cells. J Mol Cell Cardiol. 1979 Apr;11(4):415–422. doi: 10.1016/0022-2828(79)90427-9. [DOI] [PubMed] [Google Scholar]
- Villani F., Piccinini F., Merelli P., Favalli L. Influence of adriamycin on calcium exchangeability in cardiac muscle and its modification by ouabain. Biochem Pharmacol. 1978 Mar 15;27(6):985–987. doi: 10.1016/0006-2952(78)90429-x. [DOI] [PubMed] [Google Scholar]